You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

117 search results for: type 2 inflammation

Connecting the Dots from <b>Type</b> <b>2</b> <b>Inflammation</b> to Patient Perspectives
expert video

Connecting the Dots from Type 2 Inflammation to Patient Perspectives

Type 2 Inflammation
Learn the connection between chronic type 2 inflammation, symptoms, and impact on quality of life in diseases with underlying type 2 inflammation
View more
Role of <b>Type</b> <b>2</b> <b>Inflammation</b> Across Different Chronic Diseases
expert video

Role of Type 2 Inflammation Across Different Chronic Diseases

Type 2 Inflammation
Profs. Oscar Palomares, Stephan Weidinger, Valerie Lund, and Ulrike von Arnim highlight how underlying type 2 inflammation contributes to key symptoms of inflammatory diseases across organs
View more
The Path to Nodules: <b>Type</b> <b>2</b> <b>Inflammation</b> at the Core of Chronic Itch and Fibrosis in Prurigo Nodularis
expert video

The Path to Nodules: Type 2 Inflammation at the Core of Chronic Itch and Fibrosis in Prurigo Nodularis

Type 2 Inflammation
Join Dr. Shawn Kwatra in discussing the diverse clinical presentations of PN and the role of type 2 inflammation in disease pathogenesis.
View more
Role of <b>Type</b> <b>2</b> <b>Inflammation</b> in Skin Barrier Dysfunction in AD
expert video

Role of Type 2 Inflammation in Skin Barrier Dysfunction in AD

Type 2 Inflammation
Dr. Robert Bissonnette explains the role of type 2 inflammation in skin barrier dysfunction and how regulation of type 2 inflammation can normalize the skin barrier and potentially modify the disease with early intervention.
View more
Evolving Topics in <b>Type</b> <b>2</b> <b>Inflammation</b>
expert video

Evolving Topics in Type 2 Inflammation

Type 2 Inflammation
Drs. Eric Simpson, Jonathan Spergel, and Profs. Francesca Puggioni, Ian Pavord, Peter Hellings discuss emerging topics in type 2 inflammatory diseases
View more
Impact of <b>Type</b> <b>2</b> <b>Inflammation</b> on Pediatric Atopic Dermatitis, Asthma and Eosinophilic Esophagitis
expert video

Impact of Type 2 Inflammation on Pediatric Atopic Dermatitis, Asthma and Eosinophilic Esophagitis

Type 2 Inflammation
Prof. Stephan Weidinger discusses the impact of type 2 inflammation on disease burden and clinical outcomes in pediatric patients.
View more
Trajectories of <b>Type</b> <b>2</b> <b>Inflammation</b> in Pediatric Patients
expert video

Trajectories of Type 2 Inflammation in Pediatric Patients

Type 2 Inflammation
Drs. Jonathan Spergel, Wanda Phipatanakul, Eric Simpson, Prof. Salvatore Oliva discuss pediatric patient/caregiver burden and multidisciplinary care
View more
<b>Type</b> <b>2</b> <b>Inflammation</b> Underpins Pediatric Severe Asthma
Infographic

Type 2 Inflammation Underpins Pediatric Severe Asthma

Pulmonology
Learn about the role type 2 inflammation plays in the burden and pathophysiology of severe asthma in pediatric patients.
View more
The Role of <b>Type</b> <b>2</b> <b>Inflammation</b> in Chronic Spontaneous Urticaria (CSU)
Infographic

The Role of Type 2 Inflammation in Chronic Spontaneous Urticaria (CSU)

Dermatology
A summary infographic capturing how type 2 inflammation contributes to pathological processes leading to CSU signs and symptoms.
View more
<b>Type</b> <b>2</b> <b>Inflammation</b> Digital Assessment Tool
interactivity

Type 2 Inflammation Digital Assessment Tool

Pulmonology
Learn how to assess patients for the presence of uncontrolled asthma driven by underlying type 2 inflammation.
View more
UCARE <b>2</b>0<b>2</b>3: Role of <b>Type</b> <b>2</b> <b>Inflammation</b> in CSU Pathogenesis 
expert video

UCARE 2023: Role of Type 2 Inflammation in CSU Pathogenesis 

Dermatology
Dr. Saini provides a deep dive into the pathophysiology of type 2 inflammation in CSU.
View more
Itch: The Common Thread in Dermatological <b>Type</b> <b>2</b> <b>Inflammation</b> (AD, PN, and CSU)​
expert video

Itch: The Common Thread in Dermatological Type 2 Inflammation (AD, PN, and CSU)​

Dermatology
A review of the shared and unique neuroimmune mechanisms in the generation of itch across AD, PN, and CSU.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: GreeceChange country/region